Dr. Thompson on Challenges Facing the Field of Multiple Myeloma

Michael A. Thompson
Published: Wednesday, Apr 12, 2017



Michael A. Thompson, MD, PhD, medical director, precision medicine, Vince Lombardi Cancer Clinic, Aurora Health Care, discusses challenges facing the field of multiple myeloma.

There has been an increase in the amount of drugs available for patients with multiple myeloma, but now there is the challenge of determining successful combinations, sequencing these new agents, and the costs, states Thompson.

As patients are living longer, there are certain patients experiencing central nervous system (CNS) involvement with myeloma and more extramedullary disease, both of which were previously rare in multiple myeloma.
 


Michael A. Thompson, MD, PhD, medical director, precision medicine, Vince Lombardi Cancer Clinic, Aurora Health Care, discusses challenges facing the field of multiple myeloma.

There has been an increase in the amount of drugs available for patients with multiple myeloma, but now there is the challenge of determining successful combinations, sequencing these new agents, and the costs, states Thompson.

As patients are living longer, there are certain patients experiencing central nervous system (CNS) involvement with myeloma and more extramedullary disease, both of which were previously rare in multiple myeloma.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x